Expert testimony can be critical to support or defend against invalidity challenges in AIA trials, but must be adequately explained to be effective.  In Xerox Corp. v. Bytemark, Inc., IPR2022-00624, Paper 12 (PTAB Feb. 10, 2023), Director Vidal affirmed and designated as precedential a decision from the Patent Trial and Appeal Board (PTAB) that gave … Continue reading